AXSM R&D Expenses
Axsome Therapeutics Inc · R&D Expenses
AXSM R&D Expenses
Latest reported$46.23Mperiod ending
AXSM Quarterly R&D Expenses ($815.08K → $46.23M)
Quarterly R&D Expenses
High-resolution chart · PNG
AXSM r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 46,227,000 | |
| 52,677,000 | |
| 48,791,000 | |
| 40,162,000 | |
| 49,541,000 | |
| 44,785,000 | |
| 55,006,000 | |
| 45,388,000 | |
| 49,853,000 | |
| 36,830,000 | |
| 30,803,000 | |
| 28,767,000 | |
| 20,581,000 | |
| 17,793,000 | |
| 14,693,083 | |
| 14,877,000 | |
| 15,792,000 | |
| 12,585,000 | |
| 13,781,453 | |
| 13,180,258 | |
| 14,503,326 | |
| 16,595,689 | |
| 17,384,729 | |
| 14,795,493 | |
| 10,542,957 | |
| 27,521,400 | |
| 19,205,271 | |
| 15,835,573 | |
| 11,003,142 | |
| 7,603,081 | |
| 7,151,232 | |
| 6,040,780 | |
| 5,550,532 | |
| 4,752,511 | |
| 4,493,910 | |
| 4,471,126 | |
| 5,007,361 | |
| 5,985,219 | |
| 5,806,771 | |
| 5,568,777 | |
| 5,298,060 | |
| 4,526,252 | |
| 2,207,915 | |
| 1,524,395 | |
| 1,628,394 | |
| 1,416,283 | |
| 1,347,527 | |
| 1,301,524 | |
| 815,074 | |
| 815,075 |